Reliability and Effectiveness of New Enova Preloaded Intaocular Lens and Cartridge System
1 other identifier
interventional
200
1 country
1
Brief Summary
Evaluation of the safety and efficacy of the new Enova® preloaded monofocal intraocular lens and cartridge injector system in cataract surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2025
CompletedFirst Submitted
Initial submission to the registry
August 26, 2025
CompletedFirst Posted
Study publicly available on registry
December 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 11, 2026
March 24, 2026
March 1, 2026
1.1 years
August 26, 2025
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Uncorrected Distance Visual Acuity (UDVA) - Photopic Conditions
Proportion of eyes achieving 20/20 or better uncorrected distance visual acuity under photopic conditions.
1 month postoperatively
Subjective Refractive Error
Eyes with a postoperative refractive error within ±0.50 diopters of the intended target.
1 month postoperatively
Overall Clinical Performance of the Preloaded IOL System
Surgeon-rated assessment of the general clinical performance of the preloaded system by The ENOVA PGF3 Questionnaire. This questionnaire is a 14-item, study-specific, non-validated survey developed to evaluate surgeons' experience with an intraocular lens (IOL) preloaded delivery system. Eleven items are rated on a 5-point Likert scale with the following scoring structure: 1. = Low 2. = Below Expectation 3. = Meets Expectation 4. = Above Expectation 5. = Outstanding Performance Some additional items are Yes/No questions and do not contribute to the numerical total score. The total numerical score is calculated by summing the 11 Likert-scaled items. Total score range: 11 to 55, with higher scores indicating better performance and more favorable user experience.
1 month after surgery
Secondary Outcomes (2)
Preloaded System Evaluation Patient Questionnaire
Baseline (preoperative) and 1 month postoperatively
Surgical Procedure Assessment
Intraoperative
Other Outcomes (3)
Serious Adverse Events
1 month postoperatively
Postoperative Inflammation
1 week and 1 month postoperatively
Intraocular Pressure,
1 week and 1 month postoperatively
Study Arms (1)
Patients who need cataract surgery
EXPERIMENTALParticipants will undergo standard cataract surgery using the new preloaded intraocular lens (IOL) system. The intervention involves implantation of the preloaded IOL following routine phacoemulsification techniques.
Interventions
This intervention uses a preloaded IOL delivery system, which allows for a single-use, sterile implantation during standard phacoemulsification cataract surgery. Unlike standard manually loaded IOLs, this system reduces preparation time and minimizes handling of the lens, potentially improving surgical efficiency and maintaining lens sterility.
Eligibility Criteria
You may qualify if:
- Adults of either sex.
- Age 40 years or older.
- Willing and able to provide written informed consent and comply with planned study visits and procedures.
- Healthy ocular status, with no ocular pathology other than cataract and mild refractive error.
- Potential visual acuity of 20/32 (0.2 logMAR) or better in both eyes.
- Presence of regular corneal astigmatism suitable for treatment with the study device.
- Candidates for uncomplicated cataract surgery using the study device.
You may not qualify if:
- Irregular corneal astigmatism (e.g., keratoconus).
- Corneal pathology (e.g., scar, dystrophy, pterygium, moderate to severe dry eye).
- Monocular conditions (e.g., amblyopia).
- Previous corneal surgery, including radial keratotomy, corneal refractive surgery, corneal transplantation, DSAEK, or lamellar keratoplasty.
- Previous anterior or posterior segment surgery (e.g., vitrectomy, laser iridotomy).
- Diabetic retinopathy.
- Macular pathology (e.g., age-related macular degeneration \[ARMD\], epiretinal membrane \[ERM\]).
- History of retinal detachment.
- Surgical complications that may affect study outcomes, such as:
- Decentration due to capsulorhexis issues
- Improper lens placement
- Inadequate or missing postoperative capsular support
- Posterior capsular rupture
- Vitreous loss
- Iris damage (tear, rupture, etc.)
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University Istanbul Medical Faculty Ophthalmology Department
Istanbul, Fatih, 34250, Turkey (Türkiye)
Related Publications (3)
Oshika T, Wolfe P. In vitro comparison of delivery performance of 4 preloaded intraocular lens injector systems for corneal and sclerocorneal incisions. J Cataract Refract Surg. 2019 Jun;45(6):840-846. doi: 10.1016/j.jcrs.2018.10.050. Epub 2019 Mar 8.
PMID: 30853318RESULTJoshi RS. Comparative evaluation of an automated preloaded delivery system with a non-preloaded system. Indian J Ophthalmol. 2022 Dec;70(12):4307-4311. doi: 10.4103/ijo.IJO_1635_22.
PMID: 36453335RESULTAcar B, Torun IM, Acar S. Evaluation of Preloaded IOL Delivery System and Hydrophobic Acrylic Intraocular Lens in Cataract Surgery. Open Ophthalmol J. 2018 Jun 14;12:94-103. doi: 10.2174/1874364101812010094. eCollection 2018.
PMID: 30008971RESULT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 26, 2025
First Posted
December 17, 2025
Study Start
May 10, 2025
Primary Completion (Estimated)
June 15, 2026
Study Completion (Estimated)
July 11, 2026
Last Updated
March 24, 2026
Record last verified: 2026-03